We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+7.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$4.5B
AUM Growth
+$857M
(+24%)
Cap. Flow
+$670M
Cap. Flow
% of AUM
14.88%
Top 10 Holdings %
Top 10 Hldgs %
17.64%
Holding
512
New
198
Increased
109
Reduced
79
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMSG
Amsurg Corp
AMSG
|
+$73.5M |
| 2 |
RCAP
RCS CAPITAL CORPORATION CLASS A COM
RCAP
|
+$39.5M |
| 3 |
VISN
Vistance Networks Inc
VISN
|
+$37.4M |
| 4 |
Mohawk Industries
MHK
|
+$36.3M |
| 5 |
Aramark
ARMK
|
+$31.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PF
Pinnacle Foods, Inc.
PF
|
+$34.3M |
| 2 |
Pfizer
PFE
|
+$32.3M |
| 3 |
Rockwell Automation
ROK
|
+$31.2M |
| 4 |
FRX
FOREST LABORATORIES INC
FRX
|
+$31.1M |
| 5 |
Netflix
NFLX
|
+$28.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.99% |
| 2 | Industrials | 12.65% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 9.16% |
| 5 | Energy | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
MetLife
MET
$64.3B
| $12.2M | 0.27% |
+246,840
| New | +$11.6M |
|
127
Eastman Chemical
EMN
$8.4B
| $12.2M | 0.27% |
139,904
+72,514
| +108% | +$6.3M |
|
|
VGR
128
DELISTED
Vector Group Ltd.
VGR
| $12.2M | 0.27% |
1,112,594
+402,537
| +57% | +$4.41M |
|
129
Teva Pharmaceuticals
TEVA
$40.6B
| $12.1M | 0.27% |
231,640
-143,360
| -38% | -$7.33M |
|
|
DCH
130
Dauch Corp
DCH
$1.35B
| $12M | 0.27% |
+637,122
| New | +$11.7M |
|
131
Ashland
ASH
$3.32B
| $12M | 0.27% |
224,840
+155,922
| +226% | +$7.78M |
|
132
EOG Resources
EOG
$71.4B
| $11.9M | 0.26% |
101,750
-67,816
| -40% | -$7.13M |
|
133
Graphic Packaging
GPK
$3.51B
| $11.7M | 0.26% |
1,002,590
+721,625
| +257% | +$7.73M |
|
|
TQNT
134
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
| $11.7M | 0.26% |
+739,204
| New | +$11M |
|
135
Lear
LEA
$7.93B
| $11.6M | 0.26% |
+130,140
| New | +$11.2M |
|
|
RKUS
136
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $11.6M | 0.26% |
975,935
+835,454
| +595% | +$8.87M |
|
|
CYT
137
DELISTED
CYTEC INDS INC
CYT
| $11.6M | 0.26% |
219,972
+107,582
| +96% | +$5.31M |
|
138
Textron
TXT
$15.1B
| $11.5M | 0.26% |
+299,929
| New | +$11.7M |
|
|
PBPB
139
DELISTED
Potbelly
PBPB
| $11.5M | 0.25% |
718,682
+583,819
| +433% | +$9.53M |
|
140
American Airlines Group
AAL
$10.6B
| $11.4M | 0.25% |
+266,031
| New | +$10.4M |
|
141
Crown Holdings
CCK
$13.2B
| $11.4M | 0.25% |
229,522
+167,710
| +271% | +$8.04M |
|
|
CLGX
142
DELISTED
Corelogic, Inc.
CLGX
| $11.4M | 0.25% |
375,000
+122,133
| +48% | +$3.53M |
|
143
Eagle Materials
EXP
$6.48B
| $11.3M | 0.25% |
120,000
-177,899
| -60% | -$15.6M |
|
144
Incyte
INCY
$24B
| $11.3M | 0.25% |
+200,000
| New | +$10.2M |
|
145
RPM International
RPM
$14.8B
| $11.2M | 0.25% |
242,077
+161,160
| +199% | +$6.98M |
|
146
Oil States International
OIS
$501M
| $11.1M | 0.25% |
173,808
-173,894
| -50% | -$10.2M |
|
147
FedEx
FDX
$74.7B
| $11M | 0.24% |
+72,540
| New | +$10.1M |
|
148
Trinity Industries
TRN
$2.47B
| $10.9M | 0.24% |
347,250
-99,972
| -22% | -$2.83M |
|
|
GA
149
DELISTED
GIANT INTERACTIVE GROUP INC ADR (CAYMAN ISLANDS)
GA
| $10.9M | 0.24% |
921,633
+687,459
| +294% | +$8.06M |
|
150
Medtronic
MDT
$110B
| $10.8M | 0.24% |
+169,800
| New | +$10.3M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2014 Portfolio in Review
As of Q2 2014, Alyeska Investment Group held 512 positions worth $4.5B, up 24% from $3.64B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Alyeska Investment Group deployed $670M of net new capital in Q2 2014, opening 198 new positions and adding to 109 existing holdings. Its largest new stake was Amsurg Corp: 1,600,000 shares worth $72.9M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Pinnacle Foods, Inc., an estimated $34.3M trimmed.
- Alyeska Investment Group's largest Q2 2014 buy was Amsurg Corp: 1,600,000 shares worth $72.9M.
- Alyeska Investment Group added most to Capital One in Q2 2014, an estimated $18.5M increase.
- Alyeska Investment Group's biggest Q2 2014 reduction was Pinnacle Foods, Inc., cutting an estimated $34.3M.
- Alyeska Investment Group fully exited Pfizer in Q2 2014, selling an estimated $32.3M.
- Alyeska Investment Group's ten largest holdings make up 18% of its $4.5B portfolio in Q2 2014.
- Alyeska Investment Group opened 198 new positions and closed 118 in Q2 2014.
- Alyeska Investment Group's portfolio value rose 24% quarter-over-quarter to $4.5B.
Based on Alyeska Investment Group's 13F filing for Q2 2014, filed 14 Aug 2014.